期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

神经营养因子与膀胱过度活动症 被引量：2

下载PDF
导出
摘要 膀胱过度活动症（OVeractivebladder．OAB）是一种常见的膀胱功能障碍．成人发病率约10％．在老年人群中发病率则超过40％。国际尿控学会将OAB定义为：以尿急为主要表现．伴或不伴急迫性尿失禁的一种症候群．通常伴有尿频和夜尿增多．无感染证据及其他明显病理改变。由于当前缺乏有效的客观指标．OAB极易被误诊。
作者 杨江华 薛建
机构地区 北京航天总医院泌尿外科 北京市海淀医院泌尿外科
出处 《北京医学》 CAS 2013年第1期40-42,共3页 Beijing Medical Journal
关键词 膀胱过度活动症 神经营养因子 膀胱功能障碍 急迫性尿失禁 老年人群 病理改变 夜尿增多 主要表现
分类号 R694 [医药卫生—泌尿科学]
  • 相关文献

参考文献25

  • 1Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence,overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. European Urology,2006,50:1306-1315.
  • 2Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. J Neurourol Urodyn,2002,21 : 167-178.
  • 3Levi-Montalcini R. Nerve growth factor. J Science,1975,187:l13.
  • 4Guyton AC, Hall JE. Textbook of medical physiology. Philadelphia: Elsevier Saunders,2006:573-578.
  • 5Clemow DB, Steers WD, Tuttle JB. Stretch-activated signaling of growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats. J Cell Physiol,2000,183:289-300.
  • 6Liu HT, Chancellor MB, Kuo HC. Urinary Nerve Growth Factor Levels Are Elevated in Patients With Overactive Bladder and Do Not Significantly Increase With Bladder Distention. J Neurourology and Urodynamics,2009,28:78-81.
  • 7Liu HT, Kuo HC. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. J Urology,2008,72:104-108.
  • 8Vizzard MA. Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury. J Prog Brain Res,2006,152:97-115.
  • 9] Seki S, Sasaki K, Igawa Y, et al. Detrusor over-activity induced by increased levels of nerve growth factor in bladder 'afferent pathways in rats. J Neurourol Urodyn,2003,22:375-377.
  • 10Guerios SD, Wang ZY, Bjorling DE. Nerve growth factor mediates peripheral mechanical hypersensitivity that accompanies experimental cystitis in mice. J Neurosci Lett,2006,392:193-197.

二级参考文献45

  • 1江海红,卢根生,文前军,宋波.逼尿肌不稳定大鼠中RyR通道对自发性收缩影响的实验研究[J].第三军医大学学报,2005,27(8):734-736. 被引量：3
  • 2封建立,宋波.不稳定逼尿肌Cx43基因表达及其与逼尿肌细胞间缝隙连接通讯功能的关系研究[J].第三军医大学学报,2005,27(9):825-827. 被引量：6
  • 3Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation subcommittee of the International Continence Society[ J]. Urology, 2003, 61(1) : 37 -49.
  • 4Yoshimura N. Lower urinary tract symptoms (LUTS) and bladder afferent activity [ J]. Neurourol Urodyn, 2007, 26 (6 Suppl) : 908 - 913.
  • 5Callsen-Cencic P, Mense S. Mechanisms underlying the pathogenesis of urinary bladder instability-new perspectives for the treatment of reflex incontinence[J]. Restor Neurol Neurosci, 1999, 14 (2 - 3) : 115 - 126.
  • 6Dmochowski R R, Appell R A. Advancements in pharmacologic management of the overactive bladder [ J ]. Urology, 2000, 56 (6 Suppl 1 ) : 41 -49.
  • 7Ito T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction and autonomic control in atoyloid neuropathy [J]. Clin Auton Res, 2006,16 (1): 66 -71.
  • 8Smet P J, Moore K H, Jonavicius J. Distribution and colocalization of calcitonin gene-relatcd peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder [ J]. Lab Invest, 1997, 77(1): 37-49.
  • 9Cruz F. Mechanisms involved in new therapies for overactive bladder [J]. Urology, 2004, 63(3 Suppl 1):65-73.
  • 10Uchida S, Kagitani F, Hotta H. Mechanism of the reflex inhibition of heart rate elicited by acupuncture-like stimulation in anesthetized rats [J]. Auton Neurosci, 2008, 143(1-2): 12-19.

共引文献10

同被引文献19

  • 1Abrams P,Cardozo L,Fall M,et al.The standardisation of terminology of lower urinary tract function:report from the Standardisation Sub-committee of the International Continence Society.Neurourol Urodyn,2002,21(2):167-168.
  • 2Irwin DE,Milsom I,Hunskaar S,et al.Population-based survey of urinary incontinence,overactive bladder,and other lower urinary tract symptoms in five countries:results of the EPIC study.Eur Urol,2006,50(6):1306-1314.
  • 3Wang Y,Xu K,Hu H,et al.Prevalence,risk factors,and impact on health related quality of life of overactive bladder in China.Neurourol Urodyn,2011,30(8):1448-1455.
  • 4Orasanu B,Mahajan ST.The use of botulinum toxin for the treatment of overactive bladder syndrome.Indian J Urol,2013,29 (1):2-11.
  • 5Banakhar MA,Al-Shaiji TF,Hassouna MM.Pathophysiology of overactive bladder.Int Urogynecol J,2012,23(8):975-982.
  • 6Andersson KE,Pehrson R.CNS involvement in overactive bladder:pathophysiology and opportunities for pharmacological intervention.Drugs,2003,63(23):2595-2611.
  • 7Miller J,Hoffman E.The causes and consequences of overactive bladder.J Womens Health (Larchmt),2006,15(3):251-260.
  • 8Hashitani H,Yanai Y,Suzuki H.Role of interstitial cells and gap junctions in the transmission of spontaneous Ca2 + signals in detrusor smooth muscles of the guinea-pig urinary bladder.J Physiol,2004,559(Pt2):567-581.
  • 9Cartwright R,Renganathan A,Cardozo L.Current management of overactive bladder.Curr Opin Obstet Gynecol,2008,20(5):489-495.
  • 10Abrams P,Andersson KE.Muscarinic receptor antagonists for overactive bladder.BJU Int,2007,100(5):987-1006.

引证文献2

二级引证文献6

北京医学
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部